Cargando…
Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing
Genome editing, specifically CRISPR/Cas9 technology, has revolutionized biomedical research and offers potential cures for genetic diseases. Despite rapid progress, low efficiency of targeted DNA integration and generation of unintended mutations represent major limitations for genome editing applic...
Autores principales: | Wimberger, Sandra, Akrap, Nina, Firth, Mike, Brengdahl, Johan, Engberg, Susanna, Schwinn, Marie K., Slater, Michael R., Lundin, Anders, Hsieh, Pei-Pei, Li, Songyuan, Cerboni, Silvia, Sumner, Jonathan, Bestas, Burcu, Schiffthaler, Bastian, Magnusson, Björn, Di Castro, Silvio, Iyer, Preeti, Bohlooly-Y, Mohammad, Machleidt, Thomas, Rees, Steve, Engkvist, Ola, Norris, Tyrell, Cadogan, Elaine B., Forment, Josep V., Šviković, Saša, Akcakaya, Pinar, Taheri-Ghahfarokhi, Amir, Maresca, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425386/ https://www.ncbi.nlm.nih.gov/pubmed/37580318 http://dx.doi.org/10.1038/s41467-023-40344-4 |
Ejemplares similares
-
Harnessing DSB repair to promote efficient homology-dependent and -independent prime editing
por: Peterka, Martin, et al.
Publicado: (2022) -
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo
por: Bestas, Burcu, et al.
Publicado: (2023) -
Synthetic Lethality Targeting Polθ
por: Drzewiecka, Małgorzata, et al.
Publicado: (2022) -
Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours
por: Barszczewska-Pietraszek, Gabriela, et al.
Publicado: (2022) -
Universal toxin-based selection for precise genome engineering in human cells
por: Li, Songyuan, et al.
Publicado: (2021)